Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of EUR 3.38 billion. The enterprise value is 4.54 billion.
Market Cap | 3.38B |
Enterprise Value | 4.54B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Current Share Class | 73.51M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.35% |
Shares Change (QoQ) | +0.56% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 50.00M |
Valuation Ratios
The trailing PE ratio is 110.53 and the forward PE ratio is 47.77.
PE Ratio | 110.53 |
Forward PE | 47.77 |
PS Ratio | 1.56 |
PB Ratio | 6.64 |
P/TBV Ratio | n/a |
P/FCF Ratio | 22.81 |
P/OCF Ratio | 12.49 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.51, with an EV/FCF ratio of 30.60.
EV / Earnings | 148.31 |
EV / Sales | 2.10 |
EV / EBITDA | 16.51 |
EV / EBIT | 50.43 |
EV / FCF | 30.60 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 2.45.
Current Ratio | 0.85 |
Quick Ratio | 0.73 |
Debt / Equity | 2.45 |
Debt / EBITDA | 4.52 |
Debt / FCF | 8.40 |
Interest Coverage | 1.46 |
Financial Efficiency
Return on equity (ROE) is 5.12% and return on invested capital (ROIC) is 3.35%.
Return on Equity (ROE) | 5.12% |
Return on Assets (ROA) | 2.70% |
Return on Invested Capital (ROIC) | 3.35% |
Return on Capital Employed (ROCE) | 5.60% |
Revenue Per Employee | 46,194 |
Profits Per Employee | 651 |
Employee Count | 47,256 |
Asset Turnover | 1.04 |
Inventory Turnover | 27.47 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.94% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +37.94% |
50-Day Moving Average | 18.95 |
200-Day Moving Average | 17.06 |
Relative Strength Index (RSI) | 69.22 |
Average Volume (20 Days) | 400 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of EUR 2.17 billion and earned 30.60 million in profits. Earnings per share was 0.20.
Revenue | 2.17B |
Gross Profit | 476.40M |
Operating Income | 90.20M |
Pretax Income | 37.50M |
Net Income | 30.60M |
EBITDA | 188.20M |
EBIT | 90.20M |
Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 108.00 million in cash and 1.25 billion in debt, giving a net cash position of -1.14 billion.
Cash & Cash Equivalents | 108.00M |
Total Debt | 1.25B |
Net Cash | -1.14B |
Net Cash Per Share | n/a |
Equity (Book Value) | 509.10M |
Book Value Per Share | 3.25 |
Working Capital | -84.00M |
Cash Flow
In the last 12 months, operating cash flow was 270.90 million and capital expenditures -122.60 million, giving a free cash flow of 148.30 million.
Operating Cash Flow | 270.90M |
Capital Expenditures | -122.60M |
Free Cash Flow | 148.30M |
FCF Per Share | n/a |
Margins
Gross margin is 21.94%, with operating and profit margins of 4.15% and 1.41%.
Gross Margin | 21.94% |
Operating Margin | 4.15% |
Pretax Margin | 1.73% |
Profit Margin | 1.41% |
EBITDA Margin | 8.67% |
EBIT Margin | 4.15% |
FCF Margin | 6.83% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.69%.
Dividend Per Share | 0.15 |
Dividend Yield | 0.69% |
Dividend Growth (YoY) | 25.00% |
Years of Dividend Growth | n/a |
Payout Ratio | 58.82% |
Buyback Yield | -0.35% |
Shareholder Yield | 0.34% |
Earnings Yield | 0.90% |
FCF Yield | 4.38% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Medicover AB has an Altman Z-Score of 2.04. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.04 |
Piotroski F-Score | n/a |